sorafenib has been researched along with lithium chloride in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (lithium chloride) | Trials (lithium chloride) | Recent Studies (post-2010) (lithium chloride) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 3,883 | 45 | 1,152 |
| Protein | Taxonomy | sorafenib (IC50) | lithium chloride (IC50) |
|---|---|---|---|
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | 6.53 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aktaş, E; Aras, Y; Aydoseli, A; Bilir, A; Civelek, E; Ergüven, M; Gürtekin, M; Imer, M; Sabancι, PA; Yazιhan, N | 1 |
1 other study(ies) available for sorafenib and lithium chloride
| Article | Year |
|---|---|
Sorafenib and lithium chloride combination treatment shows promising synergistic effects in human glioblastoma multiforme cells in vitro but midkine is not implicated.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cytokines; ErbB Receptors; Glioblastoma; Humans; Lithium Chloride; Midkine; Niacinamide; Phenylurea Compounds; Sorafenib | 2014 |